David Kirkpatrick

July 29, 2008

GlaxoSmithKline putting over $25M in stem cell research

Filed under: Business, Science — Tags: , , , , — David Kirkpatrick @ 1:54 am

Big pharma is getting into stem cell research in a big way — more than $25 million worth of ways. GlaxoSmithKline announced a five-year, $25M-plus collaboration with the Harvard Stem Cell Institute. This agreement is expected to develop new methods for using stem cells to screen drugs with stem cells.

From the Technology Review link:

“GSK believes stem cell science has great potential to aid the discovery of new medicines by improving the screening, identification, and development of new compounds,” said Patrick Vallance, head of drug discovery at GSK, in a statement released by the company.

Big Pharma has mostly shied away from investing in stem-cell research. But drug screening, which some scientists say is likely to be one of the biggest near-term benefits of stem cells, is a growing area of interest.

1 Comment »

  1. […] September 23, 2008 | Research […]

    Pingback by The difference between conservatives and liberals … « David Kirkpatrick — September 25, 2008 @ 2:37 am


RSS feed for comments on this post. TrackBack URI

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: